1. Home
  2. PGRU vs EOLS Comparison

PGRU vs EOLS Comparison

Compare PGRU & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PGRU
  • EOLS
  • Stock Information
  • Founded
  • PGRU 2006
  • EOLS 2012
  • Country
  • PGRU Singapore
  • EOLS United States
  • Employees
  • PGRU N/A
  • EOLS N/A
  • Industry
  • PGRU EDP Services
  • EOLS Biotechnology: Pharmaceutical Preparations
  • Sector
  • PGRU Technology
  • EOLS Health Care
  • Exchange
  • PGRU Nasdaq
  • EOLS Nasdaq
  • Market Cap
  • PGRU 1.1B
  • EOLS 1.1B
  • IPO Year
  • PGRU N/A
  • EOLS 2018
  • Fundamental
  • Price
  • PGRU $6.63
  • EOLS $16.63
  • Analyst Decision
  • PGRU Buy
  • EOLS Strong Buy
  • Analyst Count
  • PGRU 2
  • EOLS 6
  • Target Price
  • PGRU $7.00
  • EOLS $22.60
  • AVG Volume (30 Days)
  • PGRU 279.3K
  • EOLS 644.7K
  • Earning Date
  • PGRU 11-19-2024
  • EOLS 11-05-2024
  • Dividend Yield
  • PGRU N/A
  • EOLS N/A
  • EPS Growth
  • PGRU N/A
  • EOLS N/A
  • EPS
  • PGRU N/A
  • EOLS N/A
  • Revenue
  • PGRU $116,419,914.00
  • EOLS $237,260,000.00
  • Revenue This Year
  • PGRU $14.24
  • EOLS $34.62
  • Revenue Next Year
  • PGRU $18.14
  • EOLS $33.33
  • P/E Ratio
  • PGRU N/A
  • EOLS N/A
  • Revenue Growth
  • PGRU 9.47
  • EOLS 40.71
  • 52 Week Low
  • PGRU $3.15
  • EOLS $7.44
  • 52 Week High
  • PGRU $6.64
  • EOLS $17.82
  • Technical
  • Relative Strength Index (RSI)
  • PGRU 63.39
  • EOLS 52.28
  • Support Level
  • PGRU $6.56
  • EOLS $16.38
  • Resistance Level
  • PGRU $6.64
  • EOLS $17.57
  • Average True Range (ATR)
  • PGRU 0.02
  • EOLS 0.77
  • MACD
  • PGRU -0.01
  • EOLS -0.04
  • Stochastic Oscillator
  • PGRU 66.67
  • EOLS 42.51

About PGRU PropertyGuru Group Limited

PropertyGuru Group Ltd is a property technology company. The company provides digital property marketplaces to match buyers and tenants with sellers and landlords, digital marketing services for property agents and developers, SaaS-based sales process automation for property developers, a digital mortgage marketplace and brokerage, and property data consultancy services for banks, valuers and property developers. Their operating segments and reportable segments are each of its four marketplaces, Singapore, Vietnam, Malaysia and Other Asia, and Fintech and data services.

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The company's first commercial product is Jeuveau, a proprietary 900 kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the cash-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications. It generates product revenue from the sale of Jeuveau in the United States and Europe, and service revenue from distribution partners in Canada.

Share on Social Networks: